← Back to Clinical Trials
Recruiting NCT07725016

NCT07725016 Functional Movement Training Versus Functional Stability Training in Post-ACL Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07725016
Status Recruiting
Phase
Sponsor Riphah International University
Condition ACL Injury
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2025-10-15
Primary Completion 2026-07-15

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Functional Movement trainingFunctional stability training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2025-10-15 with a primary completion date of 2026-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial study will include 32 athletes aged 18-35 who had ACL surgery. After surgery, participants will be selected and assigned randomly to the Functional Movement Training or Functional Stability Training groups. The Functional Movement Training protocol will include exercise: deep squat, hurdle step, in-line lunge, active straight leg raise, trunk stability push-up, and rotatory stability etc. The Functional Stability Training protocol will emphasize exercises Single-leg squats, Balance boards or BOSU ball training, Planks and side planks., Step-ups, lunges, and agility drills. Both exercises will be performed 3 times per week for 8 weeks. The main goals will be to assess pain, balance and function and knee stability. The Numeric Pain Rating Scale (NPRS), Japanese Knee Questionnaire (JACL 25) and PRSI tools will be used for collecting data. The analysis will be conducted with SPSS software and it will include use of descriptive statistics, Normality test, independent t-tests, and paired t-tests. The significance level will be p \< 0.05 for this study.

Eligibility Criteria

Inclusion Criteria: * Male Athletes * Athletes aged between 18-35 years * Athletes who have undergone ACL reconstructive surgery within the previous 3-6 months . Exclusion Criteria: * History of multiple knee surgeries (meniscus repair, partial meniscectomy, or cartilage repair) Other lower limb injuries affecting rehabilitation * Systemic illnesses affecting musculoskeletal function * Individuals with alcohol or drug abuse issues * Those involved in other weight and balance training programs

Contact & Investigator

Central Contact

Amna Shahid, t-dpt

✉ amna.shahid@riphah.edu.pk

📞 0334-4512823

Principal Investigator

Rimza Ramzan, DPT

PRINCIPAL INVESTIGATOR

Study Principal Investigator

Frequently Asked Questions

Who can join the NCT07725016 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 35 Years, studying ACL Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07725016 currently recruiting?

Yes, NCT07725016 is actively recruiting participants. Contact the research team at amna.shahid@riphah.edu.pk for enrollment information.

Where is the NCT07725016 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07725016 clinical trial?

NCT07725016 is sponsored by Riphah International University. The principal investigator is Rimza Ramzan, DPT at Study Principal Investigator. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology